QIAGEN delivers ahead of outlook for Q2 2023 with 9% CER sales growth in non-COVID products and updates 2023 full-year outlook
Provided By GlobeNewswire
Last update: Aug 8, 2023
Venlo, the Netherlands, Aug. 08, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced results for the second quarter and first half of 2023.
Read more at globenewswire.com
